EUVIMEDEUVIMED entdecken
Crossref

Melittin-Loaded Nanoparticle Microneedles Targeting M1 Macrophage for Arthritis Treatment

Jitong Wang iD, Fan Zhao, Yu Zhang, Yuting Wen, Wenxu Wang, Jinru Hu, Chun Qiao, Ruixiang Li iD, Ruofei Du iD

Molecular Pharmaceutics · 07.07.2025 · 22 (7) · 3679-3692

DOI: 10.1021/acs.molpharmaceut.4c01383 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 29.05.2025. Verfasst von Jitong Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, People's Republi…. Hauptthemen laut MEDLINE: Melitten, Macrophages, Nanoparticles, Arthritis, Experimental. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Shanghai University of Traditional Chinese Medicine, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arthritis is a joint inflammatory disease with multiple types that significantly compromises patients' quality of life. Current therapeutic efficiency is frequently constrained by the necessity for high dosages, the requirement for frequent administration, substantial side effects, and the risk of drug resistance. New therapeutic strategies are urgently needed. Melittin (Mel), a principal component of bee venom, has potent anti-inflammatory properties; however, its clinical application is limited by its hemolytic activity. To overcome the shortage, we developed targeted nanoparticles carrying Mel (MSC@NP-FA) with 68.3 ± 1.8% encapsulation efficiency, which were loaded within a microneedle (MN) to create MSC@NP-FA-MN. This strategy allows for precise anti-inflammatory therapy while reducing the risk of hemolysis. Both in vitro and in vivo studies demonstrated that MSC@NP-FA has lower hemolytic activity than Mel (p < 0.0001) and can target inflammatory macrophages to exert anti-inflammatory effects. In vitro transdermal test showed that more nanoparticles were delivered by the MNs (84.32 ± 6.97%) than bare nanoparticles (26.30 ± 2.55%) within 24 h. Furthermore, MSC@NP-FA-MN exhibited significant therapeutic efficacy without systemic toxicity or skin irritation in an adjuvant-induced arthritis (AIA) mouse model. Our findings highlight MSC@NP-FA-MN as a promising drug delivery system and suggest a new approach for safe and precise arthritis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelittenMacrophagesNanoparticlesArthritis, ExperimentalAnti-Inflammatory AgentsAnimalsMiceMaleNeedlesRAW 264.7 CellsDrug Delivery SystemsHemolysisAdministration, CutaneousHumans

Stichwörter der Autor:innen

arthritismelittinmicroneedlespolymeric nanoparticlestransdermal drug delivery system

Substanzen

MelittenAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Innovation Research Institute of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, People's Republic of China.
  • Engineering Research Center of Modern Preparation Technology of TCM, Ministry of Education, Shanghai 201203, People's Republic of China.

ORCID-Profile: Jitong Wang, Ruixiang Li, Ruofei Du

Förderung

  • Shanghai University of Traditional Chinese Medicine
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Wang, J., Zhao, F., Zhang, Y., Wen, Y., Wang, W., Hu, J., Qiao, C., Li, R., & Du, R. (2025). Melittin-Loaded Nanoparticle Microneedles Targeting M1 Macrophage for Arthritis Treatment. Molecular Pharmaceutics, 22(7), 3679-3692. https://doi.org/10.1021/acs.molpharmaceut.4c01383

Vancouver

Wang J, Zhao F, Zhang Y, Wen Y, Wang W, Hu J, et al. Melittin-Loaded Nanoparticle Microneedles Targeting M1 Macrophage for Arthritis Treatment. Molecular Pharmaceutics. 2025;22(7):3679-3692. doi:10.1021/acs.molpharmaceut.4c01383

BibTeX
@article{Wang2025,
  author = {Wang, Jitong and Zhao, Fan and Zhang, Yu and Wen, Yuting and Wang, Wenxu and Hu, Jinru and Qiao, Chun and Li, Ruixiang and Du, Ruofei},
  title = {Melittin-Loaded Nanoparticle Microneedles Targeting M1 Macrophage for Arthritis Treatment},
  journal = {Molecular Pharmaceutics},
  year = {2025},
  volume = {22},
  number = {7},
  pages = {3679--3692},
  doi = {10.1021/acs.molpharmaceut.4c01383}
}
Kostenlos starten →